Chelford Share Discussion Threads

[pc4900074200] 18/10/2006 10:17

Nice to see some buying over the last few days
without erratic manipulation by MM's.

Will it last?

pc

[supreme mo] 17/10/2006 17:00

am happy to hold guys, seems to be nav here.. board seem more optimistic than 6 months ago!!

[bookbroker] 16/10/2006 09:41

Any opinions on this one folks, like to see a slight mark-up here to reflect future prospects and growing reputation.

[bookbroker] 12/10/2006 13:27

Are we seeing buyers starting to nibble again, outlook clearer now that results out of the way, and confidence should start to re-assert itself, stock appears cheap on a 52 week view.

[aspex] 10/10/2006 09:39

Chelford CHR and Maxima MXM make an interesting comparison.
However the MXM growth has come mainly from acquisitions.

[supreme mo] 28/9/2006 17:05

nice recovery.. seems like a steady co.

[aspex] 28/9/2006 07:17

H1 results as expected given the trading statement.
New customers and revenue good but just a little thin on next 6 months.
Up 49% on projected second half order intake is good.

[supreme mo] 23/9/2006 08:49

pc, you can buy more than you can sell on line - on fri you could buy 5k at 183 and only sell 1k at 178... not the best signs coming up to the results. However, there is clearly nav in this co.

GL all

[bernieboy] 20/9/2006 17:30

I'm going to watch some paint dry.....

[pc4900074200] 20/9/2006 10:08

My sentiments as well.

If my memory is correct large amounts of shares own by management and staff.
Do they care about share price, I think not. Their return is that they draw their
salaries.

If their salary was to drop in relation to how the share drops we might see some
improvement.

Also, they do tend to drop the share price when they have a buy in the back ground.
Low NMS and they always seem to be scratching around for shares.

pc

[largeman] 20/9/2006 09:51

And down again on 0 trades!!!! I had a lot of faith in this share once.

[money4me] 11/9/2006 20:45

finally it moved......down

[aspex] 04/9/2006 19:54

Regrettably my cash is going to Endace currently.
An even better prospect.

[largeman] 04/9/2006 15:48

Good spot aspex.

I'm considering topping up but have to check the cashflow over the next couple of days.

[bernieboy] 04/9/2006 13:13

Nice find aspex.
Are you gonna top up? If I had the cash I would be filling my boots at these levels. Didnt think that we would see them again in all honesty.

[aspex] 04/9/2006 08:20

Finally something new. The first mention of TROPOS for some time.

Almac Sciences places £¼million order for SSI TROPOS ERP solution
New system to support the continued rapid expansion of Almac Sciences

SSI has announced a major £¼ million order for its TROPOS ERP solution, from Almac Sciences, a leading provider of custom synthesis services and products to the pharmaceutical industry. Almac Sciences has ordered the TROPOS end-to-end ERP and Supply Chain solution – with project accounting and project management modules – to enhance its purchasing and inventory control, and support the end-to-end supply chain solutions within its rapidly expanding cGMP manufacturing business..

Almac Sciences ordered SSI TROPOS following a full internal review of its processes. TROPOS provides Almac Sciences with purchasing control over the entire supply management cycle for all its products and services, full inventory management over its 'lean' discrete production manufacturing, and integrated quality control that will help ensure its compliance with FDA regulations, HM Customs and Excise and other industry specific regulatory authorities. TROPOS also has full cost tracking through the business processes, so that it can seamlessly integrate with Almac Sciences existing Oracle Financials solution.

"Our previous methods for purchasing and inventory control could no longer support our rapidly expanding manufacturing business, so we needed a fully integrated, powerful system that could give us total control over our entire operation," commented Paul McQuillan, Financial Controller, Almac Sciences. "Through SSI TROPOS we have that control, enabling us to enhance and develop the standards that we work to.

"We're winning more customers and synthesising more products all the time, so we needed a solution that would not only give us visibility and control over our process, but one that is really aligned to the demands of our industry. We have specific regulations to adhere to, as well as internal quality control that must go on, and SSI proved through its TROPOS solution and its consultancy expertise that it really knows the pharmaceuticals industry," he continued.

SSI TROPOS will provide Almac Sciences with the unique combination of software, technology, experience, services and future-proofing that help ensure a seamless transition to greater and enhanced automation of purchasing and supply chain management. Additional modules ordered by Almac Sciences include TROPOS Active for event triggered workflow, TROPOS Form for document printing and TROPOS Application Designer which allows Almac Sciences to enhance and extend the system without affecting the software integrity.

"Companies in the pharmaceutical industry – as well as other regulated manufacturing sectors – are constantly realising the boundaries that paper-based processes create for their businesses," added Neville Merritt, Group Sales and Marketing Director, Chelford Group. "Through SSI TROPOS, which integrates compliance requirements and control with business process management, expanding businesses such as Almac Sciences can become more efficient throughout the supply chain process. This has tremendous benefits for the business and helps achieve rapid ROI."



About Almac Sciences
Almac Sciences, formed in 1992, is one of five divisions within the ALMAC Group, operating across drug discovery, API manufacture, clinical trials and drug product manufacture. The group has facilities in the US, London and Northern Ireland.

The main portfolio of Almac Sciences technologies and services includes: Contract R&D (at lab-pilot plant scales), custom manufacturing – including process development, scale-up, validation, multi tonne scale cGMP manufacture; analytical services; synthesis of cytotoxics; peptide, protein and oligo synthesis; chiral manufacturing and isotopic labelling.

ALMAC activities by division are: diagnostics (Almac Diagnostics); API contract research and manufacture (Almac Sciences); clinical supplies packaging, distribution and management (Almac Clinical Services); control and management of clinical trials (Almac Clinical Technologies) and formulation, development and commercial scale manufacture and packaging of finished pharmaceuticals (Almac Pharma Services).

[pc4900074200] 03/8/2006 11:42

It seems that the management are content to see the value of the share price
spiral downward to the cost of all shareholders. A 33%+ de-valuation
in the last three months.

If a potential investor was to look at the share chart as a prelude to
researching or investing in this company He would wonder if it is
worth placing his money in CHR.

As a shareholder you expect to see fluctuations in the share price and any
sizable amounts downwards normally prelude a large buy,
but in this share all we see are continued 'hits' by MM's to reduce
the price. When there are investments, the price stays where it has
fallen to or recovers by a small percentage of its loss.

Only to be 'hit' again, in the next day or so.

I have seen other companies issue a statement on any large fluctuations,
as to the well being of the company and that they know of no reason
why there has been a drop in share price

With CHR management, what do we hear?

Nothing!

One tends to start to think that they don't care about investors. They
seem to have forgotten that they have a duty of care to shareholders
and that they have been placed in positions of power to over-see our
investments.

This decline in value has gone on for over three months and we are long
overdue some form of statement that should stabilise the share.

The trading update issued in July,



showed that we have 8 new customers so why are we being
'hit' as hard by MM's on a weekly sometimes daily basis?

Today is a good example, no trades, [11:40 am] and a 1.3% reduction in
SP. Not much, you may say, but on a daily basis, it is.

CHR Management. You need to act, and soon.

6 month Results are due two months from now. Do we have to see
another 22% of our investments go down the drain before you say
anything?

We should remember that any good news in September, IMHO,
may only send the share price back to the 3# mark, where we were when
trading was not showing signs of being too weak.
That is of course if the MM's want it to go back up.

Looks to be a classic case of MM's rule and the Management don't care.
They're both getting paid at the expense of the shareholders.

pc

[largeman] 03/8/2006 10:06

Down 1.3% on no trades! what the hell is going on. small rise monday equal fall yesterday and now this!

[supreme mo] 24/7/2006 08:25

think mms are trying to bounce these - can buy 15k at 1.87 and sell only 500 at 1.80 on squaregain!! - clearly an overhang here.

[largeman] 21/7/2006 15:48

Down another 3% today. This is really taking a hammering. I wonder where the bottom is.

[bernieboy] 20/7/2006 09:39

This share was already undervalued - it really is crazy. Makes no sense at all. I would love to top up at these prices again....

[pc4900074200] 20/7/2006 09:02

Bernie its always overdone with this share.

If I had said four months ago that we would be 33% down in
several months would you have believed me then?

pc

Here we go again, 2.1% down on 2k of sold shares?

[bernieboy] 20/7/2006 08:35

PC - a lot of what you say makes sense - but £1.00 we will not see again. £1.75 is the lowest I think it could go. I think we will see people adding at this level. This is way overdone.